BridgeMD
New treatment option for Postnatal Care
Official title Use of mHealth Intervention in Improving Utilization of Postpartum Care
ClinicalTrials.gov ID: NCT06409208
What this study is testing
- What it's testing
- Despite implementation of many activities related to maternal health, maternal mortality ratio is still unacceptably high in Nepal, 239/100,000 in live births. Most maternal deaths occur within 48 hours of delivery (42.7%) and then in the late postpartum period (from 48 hours after birth to up to six weeks after childbirth) (29.5%), postpartum hemorrhage predominate as the most important cause of maternal deaths (23%), with hypertensive disorder (eclampsia/pre-eclampsia) at 14 percent.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 to 45, women only
You may be able to join if
- \- Women age 19 years and above
- III trimester pregnant lady
- Mobile phone user and able to read and understand Nepali language
- Literate and can operate mobile phone (can check text message and read)
You likely can't join if
- \- Women only come for child birth service at DH without attending ANC clinic of DH.
- Women with very sick newborn and neonatal death
- Women who has to stay hospital for longer period of time (more than 14 days)
- Women with complication during labour and delivery eg. Uterine rupture,
- Not able to come for delivery at Dhulikhel Hospital.
The study team makes the final eligibility decision.
Where it's taking place
- Dhulikhel, Bagmati, Nepal
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 19 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Dhulikhel, Bagmati, Nepal. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.